Scott E Woodman Selected Research

Scott E Woodman Research Topics

Disease

42	Neoplasms (Cancer) 05/2024 - 07/2003
36	Melanoma (Melanoma, Malignant) 01/2023 - 12/2008
8	Uveal melanoma 10/2019 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2009
4	Disease Progression 01/2018 - 11/2015
3	COVID-19 01/2023 - 10/2022
2	Infections 01/2023 - 12/2022
2	Cardiomegaly (Heart Hypertrophy) 02/2003 - 06/2002
1	Colorectal Neoplasms (Colorectal Cancer) 05/2024
1	Adenocarcinoma 05/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Delirium 01/2023
1	Overweight 01/2023
1	Thrombosis (Thrombus) 10/2022
1	Critical Illness (Critically Ill) 10/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Mesothelioma 11/2021
1	Headache (Headaches) 01/2018
1	Chills 01/2018
1	Fever (Fevers) 01/2018
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Carcinogenesis 01/2016

Drug/Important Bio-Agent (IBA)

14	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2016
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2002
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 11/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 12/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2009
4	Messenger RNA (mRNA)IBA 10/2021 - 01/2016
4	IpilimumabIBA 01/2017 - 01/2011
3	Bevacizumab (Avastin)FDA Link 05/2024 - 11/2021
3	atezolizumabIBA 05/2024 - 11/2021
3	trametinibIBA 01/2021 - 08/2012
3	Caveolin 1IBA 01/2005 - 02/2003
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2021
2	dabrafenibIBA 01/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 10/2019 - 02/2003
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2010
2	HLA-A Antigens (HLA-A)IBA 01/2018 - 01/2017
2	Interleukin-2 (IL2)IBA 01/2018 - 08/2014
2	Differentiation AntigensIBA 01/2017 - 01/2013
2	AntigensIBA 01/2017 - 01/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 12/2008
2	Dasatinib (BMS 354825)FDA Link 11/2012 - 08/2009
2	Mitogen-Activated Protein KinasesIBA 08/2012 - 11/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2010 - 08/2009
2	Caveolin 3IBA 11/2003 - 10/2002
1	PlatinumIBA 02/2024
1	RamucirumabIBA 02/2024
1	Docetaxel (Taxotere)FDA Link 02/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	CarbonIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Long Noncoding RNAIBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	Keratins (Keratin)IBA 10/2021
1	Immune Checkpoint ProteinsIBA 10/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Histones (Histone)IBA 01/2021
1	ChromatinIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Blocking AntibodiesIBA 01/2018
1	Interleukin-9 (Interleukin 9)IBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2017
1	HLA-A*02:01 antigenIBA 01/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017
1	EpitopesIBA 01/2017
1	pembrolizumabIBA 10/2016
1	CytokinesIBA 02/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 01/2016
1	immune RNA (I-RNA)IBA 10/2015
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	Inosine FDA Link 10/2015
1	pertuzumabIBA 09/2015
1	Neuregulin-1 (Neuregulin 1)IBA 09/2015
1	LigandsIBA 09/2015
1	Checkpoint Kinase 1IBA 09/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2014
1	Temozolomide (Temodar)FDA LinkGeneric 08/2014
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	AlbuminsIBA 08/2014

Therapy/Procedure

33	Therapeutics 02/2024 - 09/2010
10	Immunotherapy 02/2024 - 11/2012
6	Drug Therapy (Chemotherapy) 05/2024 - 09/2014
2	Aftercare (After-Treatment) 01/2019 - 08/2014
2	Precision Medicine 01/2017 - 01/2016
1	Mechanical Ventilators (Ventilator) 12/2022
1	Length of Stay 10/2022
1	Artificial Respiration (Mechanical Ventilation) 10/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Withholding Treatment 01/2017